Slatko Gary H 4
4 · Aquestive Therapeutics, Inc. · Filed Jan 7, 2019
Insider Transaction Report
Form 4
Slatko Gary H
SVP, Chief Medical Officer
Transactions
- Award
Stock Option (Right to Purchase)
2019-01-02+75,000→ 75,000 totalExercise: $7.18Exp: 2029-01-02→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options vest in three annual installments of 25%, 25% and 50% on January 2, 2020, January 2, 2021 and January 2, 2022, respectively, subject in each case to Dr. Slatko's continuous service with the Issuer from the grant date through the applicable vesting date.